MISSISSAUGA, ON, Nov. 11 /CNW/ - YM BioSciences Inc. (NYSE Alternext
US:YMI, TSX:YM, AIM:YMBA), an oncology company that identifies, develops and
commercializes differentiated products for patients worldwide, today reported
operational and financial results for the first quarter of fiscal 2009, ended
September 30, 2008.
